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ABSTRACT
Objectives: To investigate whether low self-rated
health (SRH) is associated with increased mortality in
individuals with diabetes.
Design: Population-based prospective cohort study.
Setting: Enrolment took place between 1992 and 2000
in four centres (Bilthoven, Heidelberg, Potsdam,
Umea ˚) in a subcohort nested in the European
Prospective Investigation into Cancer and Nutrition.
Participants: 3257 individuals (mean 6 SD age was
55.867.6 years and 42% women) with conﬁrmed
diagnosis of diabetes mellitus.
Primary outcome measure: The authors used Cox
proportional hazards modelling to estimate HRs for
total mortality controlling for age, centre, sex,
educational level, body mass index, physical inactivity,
smoking, insulin treatment, hypertension,
hyperlipidaemia and history of myocardial infarction,
stroke or cancer.
Results: During follow-up (mean follow-up 6 SD was
8.662.3 years), 344 deaths (241 men/103 women)
occurred. In a multivariate model, individuals with low
SRH were at higher risk of mortality (HR 1.38, 95%
CI 1.10 to 1.73) than those with high SRH. The
association was mainly driven by increased 5-year
mortality and was stronger among individuals with
body mass index of <25 kg/m
2 than among obese
individuals. In sex-speciﬁc analyses, the association
was statistically signiﬁcant in men only. There was no
indication of heterogeneity across centres.
Conclusions: Low SRH was associated with increased
mortality in individuals with diabetes after controlling
for established risk factors. In patients with diabetes
with low SRH, the physician should consider a more
detailed consultation and intensiﬁed support.
INTRODUCTION
Patients with diabetes have a 1.5e2.5-fold
higher risk of death compared to a non-dia-
betic population.
1e4 The excess mortality in
patients with diabetes is mainly caused by
a higher risk of cardiovascular (CV)
mortality,
34but mortality due to cancer is
also increased.
5 It is of great importance to
identify patients with diabetes with high risk
of CV morbidity and mortality early on in the
disease process in order to intervene with
medication and lifestyle changes.
6 Hence,
risk engines
7 or risk scores
8 have been
developed to identify the subjects at highest
risk of developing CV. None of these tools
have used subjective measures of health.
Self-rated health (SRH) is a subjective
measure of health usually deﬁned by
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ARTICLE SUMMARY
Article focus
- Is low self-rated health (SRH) associated with
increased mortality in individuals with diabetes?
- If so, is the association between SRH and
mortality in individuals with diabetes moderated
by socio-demographic and health-related
variables?
Key messages
- Low SRH was associated with increased
mortality in individuals with diabetes after
controlling for established risk factors. The
association was homogeneous across the four
European Prospective Investigation into Cancer
and Nutrition centres situated in three different
European countries.
- The association between low SRH and mortality
was mainly driven by increased 5-year mortality
in men and was stronger among individuals with
body mass index <25 than among obese
individuals.
Strengths and limitations of this study
- To our knowledge, this is the ﬁrst study that
evaluates this research question in a population-
based cohort of individuals with diabetes with
long-term follow-up (up to a maximum of
14 years) in different European countries.
- The association between SRH and mortality
remained robust after controlling for potential
confounders, including previous myocardial
infarction, stroke or cancer, but we cannot rule
out residual confounding from other comorbidity
that was not assessed at baseline.
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Open Access Researchresponses to a single question such as ‘How do you rate
your health?’ SRH has been associated with future health
outcomes, such as cardiovascular events
9 and mortality
both in representative community samples
10 and in
deﬁned patient cohorts.
11e13 Although there is no
consensus on what SRH really represents, SRH is
drawing increasingly attention as a key parameter in
healthcare, including health policy evaluation, popula-
tion surveys and research.
14 Previous research in
different populations has suggested that the predictive
strength of SRH for subsequent mortality may differ by
sex,
15 age,
16 race,
17 education level
18 and experience of
chronic disease.
19 Studies evaluating SRH among indi-
viduals with diabetes are scarce. One previous study
showed that SRH predicted vascular events and major
complications in patients with diabetes.
20
The primary aim of this study was to investigate
whether low SRH is associated with increased mortality
in individuals with diabetes. Prospective studies investi-
gating this research question have been restricted to
short-term mortality (up to 4 years),
21 22 whereas we
can present data from a study with a mean follow-up
of 8.6 years. As a secondary aim we investigated
whether socio-demographic and health-related variables
moderate the association between SRH and mortality in
this cohort of individuals with diabetes.
METHODS
Study population
The study was nested in the European Prospective
Investigation into Cancer and Nutrition (EPIC). EPIC is
an ongoing cohort study, which consists of 519978 men
and women from 10 European countries. A detailed
description of the study design and methods can be
found elsewhere.
23 24 Participants were 35e70 years at
enrolment between 1992 and 2000 and were recruited
predominantly from the general population residing in
a given geographic area. Participants gave their written
consent, and the study was approved by the ethical
review boards of the International Agency for Research
on Cancer and by the review boards at the local centres
where participants had been recruited for the EPIC
study. Originally, the EPIC centres in Denmark,
Germany, Italy, Spain, Sweden and the Netherlands
contributed 7048 cases of self-reported diabetes at
baseline. Self-reports of diabetes obtained at baseline
were conﬁrmed by additional information sources,
which include the following depending on the available
options in the different countries: contact with a medical
practitioner, use of diabetes-related medication (eg,
insulin and blood-glucose-lowering drugs), repeated self-
report during follow-up, linkage to diabetes registries or
a measure of glycated haemoglobin (HbA1c) above
6%.
25 A total of 5542 cases of diabetes mellitus could be
conﬁrmed. We also included 870 participants whose
diabetes diagnosis was conﬁrmed within another project
in EPIC, leading to a subcohort of 6412 individuals with
conﬁrmed diabetes at baseline.
26 For the current study,
only EPIC study centres that could provide data on SRH
were included (Germany: Heidelberg and Potsdam; the
Netherlands: Bilthoven; Sweden: Umea ˚). For this reason,
3155 participants (from the centres in Denmark, Italy
and Spain) were excluded. The ﬁnal data set therefore
comprised 3257 participants from four EPIC study
centres with a conﬁrmed diagnosis of diabetes mellitus
at baseline. No clear separation between type 1 and type
2 diabetes could be made.
Assessment of SRH
SRH was assessed at baseline using self-administered
questionnaires in the native language. The question-
naires were somewhat differently formulated at each
centre and were therefore standardised (described in
online appendix). Given the low frequency of responses
in the extreme categories (n¼316 in the highest and
n¼241 in the lowest), we dichotomised the SRH variable
by combining the two highest categories (high SRH) and
the two lowest categories (low SRH) in conformity with
previous studies.
12 17 21
Covariates and outcome
Weight and height were measured with participants not
wearing shoes. Each participant’s body weight was
corrected for clothing worn during measurement in
order to reduce heterogeneity due to protocol differ-
ences among centres.
27 Body mass index (BMI) was
calculated after measurement of body weight and height,
as weight (in kilograms) divided by height (in metres
squared). Overweight was deﬁned as a BMI of
25e29.9 kg/m
2 and obesity as $30 kg/m
2 according to
the WHO guidelines. Underweight was deﬁned as a BMI
of <20 kg/m
2. Since there were only 43 persons with
underweight, we merged underweight with the normal
BMI category. For the blood pressure measurements,
uniform procedures were recommended. Hypertension
was deﬁned by a hypertension diagnosis or use of
hypertensive medication or blood pressure $140/
90 mm Hg. Further health-related variables were
collected using questionnaires, including questions on
educational level, smoking status (current smoker vs
non-smoker or ex-smoker), physical activity level and
medical history including history of myocardial infarc-
tion (MI), stroke and cancer. Physical inactivity was
deﬁned using the Cambridge Index.
28 Hyperlipidaemia
was deﬁned by use of medication for hyperlipidaemia.
Participants were followed from study entry until
death, emigration, withdrawal or end of follow-up
period. Causes and dates of deaths were ascertained
using record linkages with central cancer registries,
death indexes or by follow-up mailings and subsequent
enquiries to municipality registries, regional health
departments, physicians or hospitals. Mortality data were
coded following the 10th revision of the International
Classiﬁcation of Diseases, Injuries and Causes of
Death (ICD-10). ICD-10 codes I00eI99 were used to
calculate proportions of cardiovascular mortality. HRs
were calculated for all-cause mortality only since we
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Diabetes, self-rated health and mortalitydid not have statistical power for analyses of speciﬁed
mortality.
Statistical analyses
c
2 Test was used for testing proportions in categorical
variables. KruskaleWallis test was used for signiﬁcance
testing in continuous variables. HRs and 95% CIs were
estimated using Cox proportional hazards models. Age
was used as the primary time variable, with entry time
deﬁned as the subject’s age in years at recruitment and
exit time deﬁned as the subject’s age in years at death or
censoring. Multivariate models were constructed to
determine HRs adjusted for covariates. Age, centre, sex,
BMI, physical inactivity, insulin treatment, hypertension
and history of MI, stroke or cancer were tested as cova-
riates and included in the multivariate model since they
met the criteria of being signiﬁcantly associated with
both SRH and mortality during follow-up in men or in
women. Given the low frequencies of previous MI, stroke
and cancer, these covariates were combined in one
variable in the multivariate analysis to ensure a good
model ﬁt. Interaction was tested by including interaction
terms in the Cox proportional hazards analysis. The HRs
were combined across centres using random-effects
meta-analysis, and I
2dthe percentage of variation
between centres due to real heterogeneitydwas calcu-
lated. The ﬁrst sensitivity analysis was performed to see if
the strength of the association between SRH and
mortality differed for short-term mortality and long-term
mortality. Short-term mortality was deﬁned as death
within 5 years and long-term mortality as death after
5 years or more. This cut-off point was close to the
median follow-up time of the decedents (5.4 years). The
second sensitivity analysis was performed by excluding
participants with underweight (BMI <20 kg/m
2). A
p value <0.05 was considered signiﬁcant. All analyses
were performed using SPSS Statistics V.19.0 except
for the I
2 index test, which was performed using
Comprehensive Meta-Analysis V.2.
Missing values
There was no information on history of stroke and cancer
from the centre in Umea ˚( n ¼427), and these missing
values were assigned to a separate category in multivar-
iate analysis. The proportions of missing values for other
variables were all <2.5% and coded as missing in multi-
variate analysis. Consequently, 85 persons including eight
decedents were lost in the multivariate analysis.
RESULTS
The mean follow-up time was 8.6 years (62.3). Baseline
characteristics for the 1903 men and 1354 women are
presented in table 1. Mean age at baseline was 56.2 years
(67.1) for men and 55.4 years (68.2) for women.
Among the 3257 persons included in the study, there
were 241 deaths (13%) in men and 103 deaths (8%) in
women. Of the 344 persons who died, 40% were
cardiovascular deaths, 52% were non-cardiovascular
deaths and in 8%, the cause of death was unknown.
Table 2 shows the baseline characteristics in relation to
categories of SRH. Persons with low SRH were younger,
more frequently women, had higher BMI and had more
frequently a history of MI or stroke compared to persons
with high SRH. Moreover, in men with low SRH, insulin
treatment was more common, and in women with low
SRH, hypertension and a history of cancer were more
common.
In a model adjusted for age and centre, low SRH was
associated with increased mortality (table 3). In sex-
speciﬁc analyses, this association was signiﬁcant in men
but not in women. After further adjustments for poten-
tial confounders, the association between low SRH and
mortality was attenuated but remained signiﬁcant in
men and in both sexes combined. The fully adjusted HR
for both sexes was 1.38 (95% CI 1.10 to 1.73). In
a sensitivity analyses, we calculated HRs for low SRH for
short-term mortality (participants who died within
5 years of follow-up, n¼158) and long-term mortality
(participants who died after 5 years or more, n¼186).
HR of low SRH for short-term mortality was 1.91 (95% CI
1.30 to 2.80) for men and 1.38 (95% CI 0.75 to 2.55) for
women in the fully adjusted model. HR of low SRH
for long-term mortality was 1.24 (95% CI 0.85 to 1.79)
for men and 0.94 (95% CI 0.53 to 1.67) for women in the
same multivariate model.
Interaction analyses were performed between SRH
and covariates in relation to mortality. We found
Table 1 Baseline characteristics of 3257 individuals with
diabetes participating in the European Prospective
Investigation into Cancer and Nutrition
Men
(N[1903)
Women
(N[1354)
Age (years) 56.2 (7.1) 55.4 (8.2)
Self-rated health
High
Excellent 10.5 8.6
Good 54.1 49.9
Low
Moderate 28.4 33.5
Poor 7.0 8.0
Education
None 0.6 1.8
Primary school 35.0 43.9
Technical/professional school 29.1 33.7
Secondary school 6.8 7.6
Longer (including
university degree)
28.6 13.1
Body mass index (kg/m
2) 28.6 (4.3) 29.5 (5.6)
Current smoking 24.0 16.2
Physical inactivity 26.8 33.0
Insulin treatment 22.8 24.3
Hypertension 70.0 71.3
Hyperlipidaemia 21.8 18.5
History of myocardial infarction 9.2 3.8
History of stroke 3.5 3.0
History of cancer 4.1 6.4
Data are presented as per cent or mean (SD).
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Diabetes, self-rated health and mortalitya signiﬁcant interaction between SRH and BMI with
Pinteraction value 0.03. When analysing HRs for SRH in
different categories of BMI, we found stronger associa-
tions between SRH and mortality at lower levels of BMI,
indicating an antagonistic interaction (table 4). For
example, in the category normal or underweight, the
fully adjusted HR for both sexes combined was 2.95 (1.71
to 5.10) compared to 1.14 (0.79 to 1.65) in obese indi-
viduals. Consequently, we performed a second sensitivity
analysis by excluding persons with underweight (BMI
<20 kg/m
2, 43 persons) from the main analysis of SRH
and mortality, which attenuated the fully adjusted HR
from 1.38 to 1.36 (1.08 to 1.70) in both sexes combined.
We found no statistical interaction between SRH
and sex (Pinteraction value 0.30), age (Pinteraction value
0.22), education level (Pinteraction value 0.14), smoking
(Pinteraction value 0.13), physical inactivity (Pinteraction
value 0.24), insulin treatment (Pinteraction value 0.18),
hypertension (Pinteraction value 0.23), hyperlipidaemia
(Pinteraction value 0.16) and history of MI, stroke or
cancer (Pinteraction value 0.29).
Figure 1 shows a forest plot with adjusted HRs for low
SRH by sex and in both sexes combined for each centre.
We found no clear indication of heterogeneity in the
association between SRH and mortality across centres
(I
2 index¼0).
DISCUSSION
We found that low SRH was associated with an
increased risk of mortality in individuals with diabetes
after adjusting for major established risk factors. This
association was homogeneous across the four EPIC
centres situated in three different European countries.
The strength of the association between SRH and
mortality in this study was similar to results in general
populations.
29 In sex-speciﬁc analyses, we found that
the association between SRH and mortality was signiﬁ-
cant in men but not in women. However, the HR in
women pointed in the same direction as in men, and we
cannot rule out that the lack of signiﬁcance was due to
the lower statistical power to detect an association in
women. Interestingly, the association between SRH and
Table 2 Baseline characteristics in relation to categories of self-rated health
Men
p Value
Women
p Value
Self-rated health Self-rated health
High Low High Low
Excellent Good Moderate Poor Excellent Good Moderate Poor
Age (years) 57.1 56.6 55.2 55.4 <0.001 53.8 55.8 55.4 54.1 0.001
Education (%)
None 0.5 0.5 0.7 0.8 0.42 1.7 1.5 2.0 2.9 0.40
Primary school 35.9 33.1 36.8 42.4 35.3 44.6 44.5 44.8
Technical/professional
school
31.8 28.4 29.3 28.8 41.4 33.2 32.3 34.3
Secondary school 6.6 6.7 7.5 4.5 8.6 6.3 9.8 5.7
Longer (including
university degree)
25.3 31.3 25.7 23.5 12.9 14.5 11.4 12.4
BMI (kg/m
2) 28.6 28.4 28.9 29.0 0.05 28.1 29.2 30.0 31.1 <0.001
Current smoking (%) 25.5 23.4 24.8 23.7 0.89 16.4 15.6 15.4 21.3 0.49
Physical inactivity (%) 20.6 26.3 26.6 41.1 0.001 18.3 32.8 35.8 39.8 0.002
Insulin treatment (%) 15.2 20.8 27.4 29.2 0.002 18.1 23.0 28.0 24.1 0.15
Hypertension (%) 67.5 68.5 74.0 70.7 0.11 56.9 72.4 72.3 75.0 0.004
Hyperlipidaemia (%) 22.0 20.4 24.1 21.8 0.42 14.7 18.6 19.0 20.4 0.69
History of myocardial
infarction (%)
9.0 6.9 11.5 17.3 <0.001 1.7 2.4 6.0 4.6 0.009
History of stroke (%) 2.8 2.4 4.5 9.5 0.001 1.0 2.1 4.7 3.3 0.07
History of cancer (%) 5.1 5.1 3.6 5.7 0.61 4.9 5.8 6.1 14.3 0.02
Data are presented as per cent or mean.
Table 3 HRs of low (moderate or poor) versus high (excellent or good) self-rated health for all-cause mortality during follow-up
Model 1*, HR (95% CI) Model 2y, HR (95% CI) Model 3z, HR (95% CI)
Both sexes 1.56 (1.25 to 1.94) 1.49 (1.19 to 1.86) 1.38 (1.10 to 1.73)
Men 1.75 (1.35 to 2.27) 1.63 (1.25 to 2.12) 1.52 (1.16 to 1.98)
Women 1.35 (0.90 to 2.03) 1.21 (0.80 to 1.83) 1.11 (0.73 to 1.69)
*Adjusted for age and centre.
yAdjusted for age, centre, sex, body mass index, physical inactivity, insulin treatment and hypertension.
zAdjusted for age, centre, sex, body mass index, physical inactivity, insulin treatment, hypertension and history of myocardial infarction, stroke
or cancer.
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Diabetes, self-rated health and mortalitymortality was stronger among individuals with BMI of
<25 kg/m
2 than among obese individuals in both men
and women. This ﬁnding could possibly be explained
by the presence of other chronic diseases leading to low
body weight, low SRH and higher risk of premature
death. However, the association between low SRH and
mortality remained signiﬁcant even after the exclusion
of persons with BMI of <20 kg/m
2. Therefore, there
are likely other factors contributing to the weaker
association between SRH and overall mortality in obese
individuals with diabetes. First, we found that the
proportion of cardiovascular mortality was highest
among obese individuals in both men and women,
suggesting that the mortality pattern may be different at
different levels of BMI. Previous research has shown
that the link between SRH and mortality may be weaker
for cardiovascular mortality than for cancer mortality or
mortality from other causes.
30 Second, we found that
the obese individuals rated their health lower than
individuals with normal weight, which is in line with
studies on general populations.
31 Previous studies have
shown that obese persons may experience discrimina-
tion, stigmatisation and major limitations in daily life
linked to their obesity.
32 33 These factors will likely have
a considerable impact on their health perception. We
hypothesise that these factors related to obesity may
overshadow other important health problems or health
behaviours in the perception of health and possibly
weaken the association between SRH and mortality in
obese individuals.
Table 4 HRs of low versus high self-rated health for all-cause mortality by categories of BMI
BMI classiﬁcation
BMI
(kg/m
2)
CV
mortality (%)
Model 1*, HR
(95% CI)
Model 2y,H R
(95% CI)
Model 3z,H R
(95% CI)
Both sexes Normal or underweight
(n¼646)
<25 38.3 2.81 (1.65 to 4.79) 3.12 (1.81 to 5.37) 2.95 (1.71 to 5.10)
Overweight (n¼1408) 25e29.9 37.3 1.46 (1.05 to 2.03) 1.34 (0.96 to 1.89) 1.22 (0.87 to 1.71)
Obesity (n¼1203) $30 45.0 1.29 (0.90 to 1.85) 1.20 (0.83 to 1.72) 1.14 (0.79 to 1.65)
Men Normal or underweight
(n¼359)
<25 39.5 2.77 (1.49 to 5.15) 3.61 (1.90 to 6.85) 3.57 (1.88 to 6.78)
Overweight (n¼921) 25e29.9 39.0 1.62 (1.12 to 2.36) 1.45 (0.99 to 2.14) 1.33 (0.90 to 1.95)
Obesity (n¼623) $30 47.5 1.57 (1.00 to 2.47) 1.38 (0.87 to 2.18) 1.31 (0.83 to 2.08)
Women Normal or underweight
(n¼287)
<25 35.3 3.14 (1.10 to 8.94) 2.47 (0.79 to 7.66) 1.87 (0.59 to 6.00)
Overweight (n¼487) 25e29.9 31.4 1.20 (0.61 to 2.38) 1.04 (0.51 to 2.11) 0.93 (0.45 to 1.91)
Obesity (n¼580) $30 41.2 1.05 (0.56 to 3.85) 0.95 (0.52 to 1.74) 0.92 (0.50 to 1.69)
*Adjusted for age and centre.
yAdjusted for age, centre, sex, BMI, physical inactivity, insulin treatment and hypertension.
zAdjusted for age, centre, sex, BMI, physical inactivity, insulin treatment, hypertension and history of myocardial infarction, stroke or cancer.
BMI, body mass index; CV, cardiovascular.
Figure 1 Forest plot showing
adjusted HRs and 95% CIs for the
centres included in the study
investigating the association
between low self-rated health and
mortality in individuals with
diabetes.
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Diabetes, self-rated health and mortalityThe association between SRH and mortality has been
of interest in medical research for several decades.
Already in 1973, Maddox, one of the pioneers in this
research ﬁeld stated that SRH “clearly measure some-
thing moredand something lessdthan objective
medical ratings”.
34 It is still debated what information
individuals rely on when rating their health. Qualitative
research has suggested that SRH reﬂects a combination
of speciﬁc health problems, general physical functioning
and health behaviours.
35 Cultural differences may also
have an impact on SRH, even within Europe.
36 A
previous quantitative study from The National Health
and Nutrition Examination Survey (NHANES) found
that low SRH is particularly predictive for respondents
with self-reported history of circulatory system diagnoses
and perception of symptoms but not for respondents
without symptoms or diagnoses.
19
Only a few studies have evaluated the association
between SRH and mortality in well-deﬁned cohorts of
patients with diabetes.
21 22 37 In 1994, Dasbach and
colleagues found increased mortality in 987 patients with
older onset of diabetes who rated their health as worse
than other people of similar age. The average age in their
study was 64.7 years (611.0) compared to 55.8 years
(67.6) in our study. More recently, McEwen and
coworkers
21 found that SRH predicted mortality in an
American multiethnic cohort of over 7000 patients with
diabetes. However, their study was restricted to patients
with longer duration of diabetes (diagnosed at least
18 months before survey) in managed care and a rela-
tively short follow-up (the average length was 3.7 years).
In the FIELD study, a controlled trial of fenoﬁbrate
performed in Australia, New Zealand and Finland, the
mean duration of follow-up was even shorter, only
2.4 years. In this study involving 7348 patients with dia-
betes, Clarke and colleagues
22 found that low SRH was
associated with vascular events, diabetes complications
and all-cause mortality. In our study, which was popula-
tion-based, the participants were younger and followed
for an average of 8.6 years. We found that the association
between SRH and mortality was weaker and no longer
statistically signiﬁcant when we restricted the analysis to
long-term mortality. These ﬁndings raise questions about
the long-term predictiveness of a single self-rating of
health and we therefore suggest that future research in
individuals with diabetes should include repeated self-
ratings and follow-up for long-term mortality.
There are some limitations in our study. Even if the
association between SRH and mortality was robust when
individuals with underweight were excluded, we cannot
rule out other potential residual confounding from
comorbidity other than MI, stroke or cancer that was not
assessed at baseline health examinations. Moreover, the
sample size in the present study did not allow any clear
conclusions in relation to sex-speciﬁc analyses, and we
could not make a separation between type 1 and type 2
diabetes. The questions and the response alternatives on
SRH were formulated somewhat differently and in the
native language at each centre. The questions and
answers were translated and standardised in four
response alternatives, which may have led to some
degree of misclassiﬁcation, particularly for the centres in
Bilthoven and Umea ˚ (which had ﬁve response alterna-
tives). However, the forest plot gave no indication that
the standardisation in four response alternatives had
a major impact on the risk estimates. The multivariate
models used in this study were similar but not identical
with equations used in risk engines
7 and risk scores.
8
Whether SRH adds predictive value over and above these
models needs to be further analysed in future studies
using adequate methods.
38
Although more research is needed to gain a more
complete understanding of the relationship between
SRH and mortality in individuals with diabetes, we ﬁnd
that self-ratings of health are an inexpensive and time-
efﬁcient way to obtain subjective prognostic information
that may be difﬁcult to assess by objective health
measurements. In patients with diabetes with low
SRH, the physician should consider a more detailed
consultation and intensiﬁed support.
Conclusions
This is the ﬁrst study investigating the association
between SRH and mortality in individuals with diabetes
with a long-term follow-up in different European coun-
tries. We found that low SRH was associated with
increased mortality in individuals with diabetes after
controlling for established risk factors. The association
was mainly driven by increased 5-year mortality in men
and was stronger among individuals with BMI of
<25 kg/m
2 than among obese individuals.
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